Manufacturers Life Insurance Company, The Viking Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 24,676 shares of VKTX stock, worth $632,939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,676
Previous 24,630
0.19%
Holding current value
$632,939
Previous $1.56 Million
36.37%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding VKTX
# of Institutions
468Shares Held
65.8MCall Options Held
5.84MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$261 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$155 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$126 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$66.5 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$55.3 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $1.97B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...